The technology will be used by DefiniGEN to develop new, optimised cell products and services for drug discovery and the study of lung diseases, including cystic fibrosis. The technology, licensed to DefiniGEN by Cambridge Enterprise, the commercialisation arm of the University of Cambridge uses induced pluripotent stem cells, or iPS cells, to recreate embryonic lung development in the lab by activating a process known as gastrulation, in which the cells form...
Vivantis specialize in the production of Restriction Enzymes, DNA extraction kits, DNA amplification reagents including kits for molecular biology applications, recombinant enzymes, improved protein stains, markers and ladders. To mark this event Vivantis is running a promotion for its GF-1 Nucleic acid extraction kits. These kits provide a rapid and efficient method for purification of nucleic acid from various samples. The purification columns...
Thistle’s schemes cover:
This new office based in Cambridge, has been opened to help service the growing number of users in the UK and well as offering sales and support for a number of International dealers and customers. This expansion coincides with the Company recently being awarded a coveted German Stifterverband seal which is only given to those companies who can show new discoveries and who can create innovative solutions.....
Vivantis specialize in the production of Restriction Enzymes, DNA extraction kits, DNA amplification reagents including kits for molecular biology applications, recombinant enzymes, improved protein stains, markers and ladders. To mark this event Vivantis is running a promotion for its GF-1 Nucleic acid extraction kits. These kits provide a rapid and efficient method for purification of nucleic acid from various samples....
The contract manufacturing organisation (CMO) received no critical or major observations and this comes amidst various quality-related issues affecting several other sterile manufacturing sites in the UK and US. Symbiosis has been re-inspected and approved for the ongoing production of Investigational Medicinal Products (IMP’s) for clinical trials, In a further boost to support the growth and strategic development of the company, it received confirmation...
The company also used the prestigious occasion to officially open a third building at its Llantrisant site. The accolade was formally presented to the company at its Llantrisant headquarters by an official party including the Lord-Lieutenant of Mid-Glamorgan, Mrs Kate Thomas, and the Vice-Lord-Lieutenant, Mr Roy Noble. This follows on from an audience with the Queen and the Duke of Edinburgh at Buckingham Palace last month, attended by...
New microscopy technologies, such as light sheet fluorescence microscopy (LSFM) or clearing methods, allow the imaging of large samples at high resolution or high frame rates. Handling, processing, and analyzing these multi-terabyte data sets has become increasingly difficult for scientists, e.g. in developmental biology and neuroscience. New tools are needed to overcome these challenges. Therefore, ZEISS has teamed up with arivis AG to offer complete...
With the economic forecast for Iran being stated as 6-10% growth per year, the UAE is projected to increase its re-export trade with Iran in 2016 by 60%. This means that ARABLAB 2016 will have increased attendance from buyers and end users from the Gulf States. With no other specialist trade shows that exist in either the UAE or Iran, this agreement provides exhibitors at ARABLAB 2016 a unique opportunity to promote their products to the Iranian Market Place...
World-renowned for its lyophilisation services and molecular diagnostic products, Biofortuna has developed a new internal infrastructure, creating distinct products and services divisions and giving the company a strong focus for growth and efficiency. The breadth of the company’s portfolio of IVD manufacturing and development services has expanded to include manufacturing, dispensing, kitting, labelling, capping, as well as design and development of...
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, and Mologic, a specialist diagnostic development company and molecular reagent innovator, announced today the signing of a supply and licensing agreement for use of Innova’s Lightning-Link® and InnovaCoat® GOLD technologies as part of Mologic’s commercial assay development services and range of immunoassays. The deal provides Mologic with...
This annual award is sponsored by Vermont Business Magazine and KeyBank, and is presented to five Vermont businesses that have experienced the greatest growth over the past five years in five different categories. BioTek received the award in the TECHNOLOGY category for their impressive growth over five years. “It is an honor to be recognized as one of the fastest growing technology companies in Vermont” noted Briar Alpert, BioTek’s President...
In upholding the judicial review brought by Richmond Pharmacology, the court has found that the UK clinical trials regulator, the Health Research Authority (HRA), must be clear about what constitutes ‘guidance’ and what constitutes legal obligations. The ruling means that companies sponsoring phase one adult clinical trials in the UK retain control over whether and when they wish to make public the registration of previously conducted trials. Oliver Wright, solicitor at...
The award recognizes distinguished individuals who have strengthened links between the University and practical experience in business and industry, through seminars, lectures and research collaborations. Mark Egerton, CEO Quotient Clinical, said: “We are delighted that Peter has received this award and recognition. Peter joined our business in 2007 and has played a key role in developing Translational Pharmaceutics and its application to drug development...
ZEISS celebrates the 50th anniversary of commercial scanning electron microscopy (SEM). In 1965, the first commercial SEM called Stereoscan was built by Cambridge Instrument Company, a UK based predecessor company of Carl Zeiss Microscopy Ltd. To mark the anniversary of this very first SEM sale 50 years ago, and celebrate the contributions to scientific research across so many fields and industries made possible through scanning electron microscopy...
“This breakthrough will allow us to provide products that have the best of both worlds: the lightweight, break resistant properties of plastic with the barrier qualities and inert inner surface of pure glass,” said Wayne Brinster, president and CEO of WHEATON®. “For 126 years Wheaton has been an innovator in glass as well as plastic for laboratories. Customers look to us to solve their needs and this technology will allow us to develop purpose built products that blend the features of both glass and plastic into a single innovative solution....
In recent years, the global pharmaceutical and biotechnology industry has outperformed other sectors in terms of stock market indices. The appeal of orphan drugs and systems that reduce the cost of healthcare will continue to attract investors to fund the industry. Analysis from Frost & Sullivan, Funding Patterns in the Global Pharma and Biotech Industry, reveals the volume of venture capital (VC) deals fell by 41.2 percent between 2010 and 2014, while...
The company reports a worldwide increase in sales and support of 22.7% compared to the previous year. The outstanding performance amongst these figures was an increase in system sales of 73.6% in the UK. Autoscribe Managing Director, John Boother, said: “This is another great set of results and the company continues to enjoy a sustained period of growth due to the effort invested both in developing our products and enhancing our...
The ISO 13485 certification covers the development, production and distribution of in-vitro diagnostics (IVD) for autoimmune diseases. The certificate demonstrates that Protagen has successfully implemented a quality management system that conforms to the world-wide standard for medical device and diagnostic manufacturing. Stefan Mu?llner, Protagen CEO, stated, “We have been ISO 9001 certified for some years now. The addition of the new...